VJHemOnc is committed to improving our service to you

ICML 2019 | FOLL12 trial: response-oriented maintenance therapy for advanced follicular lymphoma

VJHemOnc is committed to improving our service to you

Massimo Federico

Massimo Federico, MD, University of Modena and Reggio Emilia, Modena, Italy, discusses response oriented maintenance therapy in advanced follicular lymphoma, explaining the results of the interim analysis of the FOLL12 trial (NCT02063685). This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter